James L. Freddo
Chief Tech/Sci/R&D Officer at TRACON PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Worland | M | 66 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 20 years |
| Charles Theuer | M | 60 | 20 years | |
| Martin Mattingly | M | 66 | 18 years | |
| Scott Brown | M | 43 | 9 years | |
| Carrie Lachance | F | 47 | 14 years | |
| Saundra Pelletier | F | 54 | 4 years | |
| Rainer Twiford | M | 71 | 16 years | |
| William LaRue | M | 73 | 10 years | |
| Carol Lam | F | 64 | 3 years | |
| Bernard Parker | M | - | 9 years | |
| Lisa Johnson-Pratt | M | 60 | 3 years | |
| Brenda Marczi | F | - | 3 years | |
| Edward Harrington | M | - | 6 years | |
| Mike McDermott | M | 58 | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stelios Papadopoulos | M | 75 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 19 years |
| Zachary Hornby | M | 45 | 6 years | |
| Kleanthis Xanthopoulos | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 19 years |
| Jonathan Lim | M | 52 | 7 years | |
| Bonne Adams | F | 47 | 19 years | |
| James Bristol | M | 77 | 9 years | |
| Bruce Resnick | M | - |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | - |
| Yi Ning Zhao | M | 53 | 8 years | |
| Christian V. Kuhlen | M | 51 | 2 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Steven Hoerter | M | 53 | 2 years | |
| Alexander Casdin | M | 56 | 5 years | |
| Timothy L. Kopra | M | 61 | 2 years | |
| Paul Fitzhenry | M | 63 | 4 years | |
| Steven E. Watkins | M | 67 | - | |
| Heiner Dreismann | M | 69 | 5 years | |
| Adrian M. Senderowicz | M | 60 | 1 years | |
| Thomas Ruiz | M | 66 | - | |
| Mark Foletta | M | 63 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 6 years |
| Matthew W. Onaitis | M | 53 | 2 years | |
| Marios Fotiadis | M | 51 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 9 years |
| David C. Dreyer | M | 67 | 10 years | |
| Mark Wiggins | M | 68 | 4 years | |
| James T. Glover | M | 74 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 3 years |
| Raymond C. Jordan | M | 70 | 17 years | |
| Ali Seyedroudbari | M | - | - | |
| John Thompson | M | 57 | 7 years | |
| James T. VanderLugt | M | - | - | |
| Krishan K. Arora | M | 83 | 5 years | |
| Dan Garofalo | M | 48 | 4 years | |
| Scott Cheshareck | M | - | 16 years | |
| Michael Pastoor | M | - | 5 years | |
| Edmund Harrigan | M | 71 | 12 years | |
| Patrick Foley | M | - | 4 years | |
| Craig M. Audet | M | 59 | 5 years | |
| Ravi Kiron | M | 64 | 13 years | |
| Sandra Rogers | F | 58 | 4 years | |
| Rajmund Ireneusz Martyniuk | M | 62 | 4 years | |
| Anna Levander | F | 47 | 3 years | |
| Michael Bruce | M | - | 12 years | |
| Lee Golden | M | 56 | 4 years | |
| William S. Korinek | M | - | 9 years | |
| John Chapman | M | 70 | 4 years | |
| Jeffrey Kent | M | 62 | 4 years | |
| Spiros Liras | M | - | 4 years | |
| Margaret Marshall | M | 67 | 8 years | |
| Muriel Cottard | M | - | 4 years | |
| Christopher Verni | M | 49 | 3 years | |
| Guy Padbury | M | - | 5 years | |
| Fei He | M | 55 | 7 years | |
| Charles McWherter | M | 69 | 4 years | |
| Peter H. Reinhart | M | - | 6 years | |
| Kenneth Bahrt | M | 71 | 4 years | |
| Pat Parr | M | - | 6 years | |
| Nat Ricciardi | M | 75 | 7 years | |
| Jean-Paul Vallès | M | - | 25 years | |
| John F. Niblack | M | 85 | 35 years | |
| Franklin Raines | M | 74 | 7 years | |
| Claus Egstrand | M | 63 | 3 years | |
| Kristin Peck | F | 52 | 8 years | |
| William Sigmund | M | - | 4 years | |
| Lance Berman | M | 53 | 6 years | |
| Robert E. Grasty | M | 55 | - | |
| Freddie Hoffman | M | 73 | 4 years | |
| Robert Karr | M | 75 | 4 years | |
| Arthur Lee Campbell | M | 73 | - | |
| John W. Poyhonen | M | 64 | 7 years | |
| Sigurdur Olafsson | M | 55 | 2 years | |
| Ian Williams | M | 70 | 23 years | |
| Daniela Oniciu | M | - | 4 years | |
| Daniel Cronin | M | 78 | - | |
| Rom Eliaz | M | 52 | 2 years | |
| Francesco Granata | M | 73 | 2 years | |
| Ngozi Edozien | F | 59 | 6 years | |
| Cristina Csimma | M | 65 |
Wyeth-Ayerst Research
| 1 years |
| Ebrahim Versi | M | 71 | 4 years | |
| Nicholas Lee Gurreri | M | - | 4 years | |
| Beth Anne Piper | M | - | 3 years | |
| Mark W. Pierce | M | 75 | 3 years | |
| Tim Bertram | M | 68 | 5 years | |
| Arthur Peter Bertolino | M | 69 | 4 years | |
| Julie A. Olson | M | - | 19 years | |
| Navin Jacob | M | - | 3 years | |
| Frank Sciavolino | M | 83 | 35 years | |
| Ryan G. Stepanian | M | - | - | |
| Seth Brodsky | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James L. Freddo
- Personal Network